Table of Contents
THE MARKET AND POTENTIAL FOR MOLECULAR POC
ONE: EXECUTIVE SUMMARY
Introduction
Molecular Point-of-Care Diagnostics Defined
Strengths and Weakness of Molecular POC Testing
Component Technologies of Molecular POC Diagnostics
Microfluidics
qPCR
Microarrays
Isothermal Amplification
Test Automation
Primers and Probes
Detection
Next-Generation Sequencing
Leading Platforms in Molecular POC Diagnostics
Investment in Decentralized Molecular Diagnostics – Venture Financing and Public
Offerings (2009-2015)
Global Molecular POC Diagnostics Market (2015-2020)
Major Conclusions
TWO: INTRODUCTION TO MOLECULAR POINT OF CARE DIAGNOSTICS
Introduction
Point-of-Care Diagnostics in Brief
Common Tests and Analytes in POC Diagnostics
Market Drivers for POC Diagnostics
Market Barriers for POC Diagnostics
Molecular Diagnostics
Real-Time PCR (qPCR)
Isothermal Amplification Methods
Microarrays
Sequencing
Common Tests and Analytes in Molecular Diagnostics
Advantages and Disadvantages of Molecular Diagnostics at the Point of Care
Summary
THREE: MOLECULAR POINT OF CARE DIAGNOSTICS DEVELOPMENT AND APPLICATIONS
Introduction
Advances in Molecular Diagnostics
Microfluidics
Isothermal Amplification
Test Automation
Primers and Probes
Detection
Next-Generation Sequencing
Molecular Platforms and Products for Decentralized Testing
Major Testing Applications for Molecular POC Diagnostics
Influenza
Strep A
Respiratory Syncytial Virus (RSV)
Other Respiratory Infections
Chlamydia and Gonorrhea
Group B Streptococcus
Human Papillomavirus
Herpes Simplex Virus
Vaginitis
Human Immunodeficiency Virus (HIV)
Tuberculosis
Hepatitis
Malaria
Other Tropical and Neglected Diseases
Gastrointestinal Infections
Hospital-Acquired Infections (HAIs)
Bloodstream Infections (BSIs)
Pharmacogenetics
Hereditary Disease
Cancer
Conclusions
FOUR: MARKETS FOR MOLECULAR POINT-OF-CARE DIAGNOSTICS
Introduction
Investment in Decentralized Molecular Diagnostics – Venture Financing and Public
Offerings (2009-2015)
Respiratory Tract Infections
Women’s Health and Sexual Health
High-Burden Diseases
Gastrointestinal, Hospital-Acquired and Bloodstream Infections
Non-Infectious Disease Tests – Pharmacogenetics, Hereditary Traits and Cancer
Conclusions
FIVE: COMPANY PROFILES
Abacus Diagnostica
Advanced Liquid Logic (Illumina)
Ahram Biosystems
Akonni Biosystems
Alere (Abbott)
Amplino
Analytik Jena
Aquila Diagnostic Systems
Atlas Genetics
Axxin
Becton, Dickinson & Co. (BD)
Biocartis
Biomeme
bioMérieux
Canon BioMedical
Cepheid
Molecular Healthcare-Acquired Infection (HAI) Testing
Molecular Sexual Health and Women’s Health Testing
Molecular Critical Infectious Disease Testing
Molecular Oncology Testing
Coris BioConcept
Coyote Bioscience
Curetis
DestiNA Genomics
Diagnostics For All
Diagnostics for the Real World
DiaSorin
DiAssess
DNA Electronics
DxNA
Eiken Chemical
Enigma Diagnostics
Entopsis
Epistem
ERBA Molecular (Lumora)
Espira
GenapSys
GeneFluidics
GenePOC
GeneReach Biotechnology
GnuBIO (Bio-Rad)
Great Basin Scientific
Greiner Bio-One
Hai Kang Life
Hain Lifescience
HiberGene Diagnsotics
iCubate
Immunexpress
InSilixa
Lucigen
Mast Group
MBio Diagnostics
Meridian Bioscience
Mesa Biotech
Metaara Medical Technologies
Micronics (Sony)
Molbio Diagnostics
MP Biomedicals
MycroLab Diagnostics
Nanobiosym
NanoBioSys
NanoDetection Technology
NanoIVD
Nanomix
Nanosphere
OptiGene
Orion Diagnostica
Oxford Nanopore Technologies
PositiveID
PreTect
QIAGEN
HPV
Other Activities (Development, Licensing, Investment)
QuantuMDX
Quidel
Rheonix
Roche Diagnostics
Scanogen
Seegene
Spartan Bioscience
STAT-Diagnostica
T2 Biosystems
Thermal Gradient
Ubiquitome
Ustar Biotechnologies
Veredus Laboratories
Wave 80 Biosciences
Xagenic
LIST OF EXHIBITS
ONE: EXECUTIVE SUMMARY
Table 1-1: Advantages of Point-of-Care Diagnostics by Setting – Hospital POC,
POL/Outpatient, Low-Resource and Developing Areas
Table 1-2: Disadvantages of Point-of-Care Diagnostics by Setting – Hospital POC,
POL/Outpatient, Low-Resource and Developing Areas
Table 1-3: Market-Available Molecular POC Diagnostic Platforms (Vendor, Assay
Menu, Planned Assays, Regulatory Status, Procedure Integration, Test
Principles)
Figure 1-1: Investments in Decentralized Molecular Diagnostics Companies
(2014-2015)
Figure 1-2: Molecular POC Diagnostics Market (2015-2020) ($ millions)
TWO: INTRODUCTION TO MOLECULAR POINT OF CARE DIAGNOSTICS
Table 2-1: Advantages of Point-of-Care Diagnostics by Setting – Hospital POC,
POL/Outpatient, Low-Resource and Developing Areas
Table 2-2: Disadvantages of Point-of-Care Diagnostics by Setting – Hospital POC,
POL/Outpatient, Low-Resource and Developing Areas
Table 2-3: Selected Isothermal Amplification Methods and Platform Examples
THREE: MOLECULAR POINT OF CARE DIAGNOSTICS DEVELOPMENT AND APPLICATIONS
Table 3-1: Selected Isothermal Amplification Methods and Platform Examples
Table 3-2: Selected Analyzer Platforms for Decentralized and POC Molecular Testing
with Image Sensor Detectors (CCD, CMOS)
Table 3-3: Selected Analyzer Platforms for Decentralized and POC Molecular Testing
with Photodiode Detectors
Table 3-4: Selected Analyzer Platforms for Decentralized and POC Molecular Testing
with Electrochemical Detectors
Table 3-5: Selected Analyzer Platforms for Decentralized and POC Molecular Testing
with Immunochromatographic Detection
Table 3-6: Selected NGS Platforms for Decentralized and POC Sequencing
Table 3-7: Market-Available Molecular POC Diagnostic Platforms (Vendor, Assay
Menu, Planned Assays, Regulatory Status, Procedure Integration, Test
Principles)
Table 3-8: Market-Available Hospital Molecular Diagnostic Platforms (Vendor, Assay
Menu, Planned Assays, Regulatory Status, Procedure Integration, Test Principles) … 83
Table 3-9: Hospital and POC Molecular Diagnostic Platforms in Development (Vendor,
Assay Menu, Procedure Integration, Test Principles)
Table 3-10: Market-Available Molecular Diagnostic Platforms for Emerging Markets
and the Developing World (Vendor, Assay Menu, Planned Assays, Regulatory Status,
Procedure Integration, Test Principles)
Table 3-11: Molecular Diagnostic Platforms in Development for Emerging Markets
and the Developing World (Vendor, Assay Menu, Procedure Integration, Test
Principles)
Table 3-12: Line Probe Assays and Other Molecular Lateral Flow Test Strips (Vendor,
Assay Menu, Planned Assays, Regulatory Status)
Table 3-13: Potential Entrants into Molecular POC Diagnostics (Vendor, Current
Platform[s], Primary Market for Platform, Assay Menu, Applicable Tech)
Table 3-14: Selected Developmental Molecular POC-Enabling Technologies and
Platforms by Vendor
FOUR: MARKETS FOR MOLECULAR POINT-OF-CARE DIAGNOSTICS
Figure 4-1: Investments in Decentralized Molecular Diagnostics Companies
(2014-2015)
Table 4-1: Investments in Decentralized Molecular Diagnostics Companies
(2014-2015)
Figure 4-2: Molecular Influenza Test POC Market (2015-2020) ($ millions) – Sales /
Market Opportunity
Figure 4-3: Molecular Strep A Test POC Market (2015-2020) ($ millions) – Sales /
Market Opportunity
Figure 4-4: Molecular RSV POC Market (2015-2020) – Sales / Market Opportunity … 135
Figure 4-5: Molecular POC Market for Other Respiratory Infections (2015-2020) –
Sales / Market Opportunity
Table 4-2: Molecular POC Market for Respiratory Tract Infections – Influenza, Strep
A, RSV, Others (2015-2020) – Sales / Market Opportunity
Figure 4-6: Molecular CT/NG POC Market (2015-2020) – Sales / Market
Opportunity
Figure 4-7: Molecular GBS POC Market (2015-2020) – Sales / Market Opportunity … 142
Figure 4-8: Molecular HPV POC Market (2015-2020) – Sales / Market Opportunity .. 144
Figure 4-9: Molecular HSV POC Market (2015-2020) – Sales / Market Opportunity … 146
Figure 4-10: Molecular Vaginitis POC Market (2015-2020) – Sales / Market
Opportunity
Table 4-3: Molecular POC Market for Women’s Health and Sexual Health – CT/NG,
GBS, HPV, HSV, Vaginitis (including TV) (2015-2020) – Sales / Market
Opportunity
Figure 4-11: Molecular HIV POC Market (2015-2020) – Sales / Market Opportunity . 152
Figure 4-12: Molecular TB POC Market (2015-2020) – Sales / Market Opportunity
Figure 4-13: Molecular Hepatitis POC Market (2015-2020) – Sales / Market
Opportunity
Figure 4-14: Molecular Malaria POC Market (2015-2020) – Sales / Market
Opportunity
Figure 4-15: Molecular POC Market for Other Tropical and Neglected Diseases (2015-
2020) – Sales / Market Opportunity
Table 4-4: Molecular POC Market for High-Burden Diseases – HIV, TB, Hepatitis,
Malaria, Other Tropical and Neglected Diseases (2015-2020) – Sales / Market
Opportunity
Figure 4-16: Molecular POC Market for GI Pathogens (2015-2020) – Sales / Market
Opportunity
Figure 4-17: Molecular POC Market for HAIs (2015-2020) – Sales / Market
Opportunity
Figure 4-18: Molecular POC Market for Bloodstream Infections (2015-2020) – Sales /
Market Opportunity
Table 4-5: Molecular POC Market for GI Pathogens, HAIs and Bloodstream Infections
(2015-2020) – Sales / Market Opportunity
Figure 4-19: Molecular POC Market for PGx and Other Genetics Testing (2015-2020) –
Sales / Market Opportunity
Figure 4-20: Molecular POC Market for Cancer Testing (2015-2020) – Sales / Market
Opportunity
Table 4-6: Molecular POC Market for Non-Infectious Diseases – Pharmacogenetics /
Hereditary Traits and Cancer (2015-2020) – Sales / Market Opportunity
Table 4-7: Molecular POC Test Markets for Respiratory Tract Infections, Women’s
Health and Sexual Health, High-Burden Diseases, GI Pathogens, HAIs, Bloodstream
Infections, Pharmacogenetics, Other Genetics, and Cancer Testing (2015-2020) –
Sales / Market Opportunity
FIVE: COMPANY PROFILES
Table 5-1: Alere Revenue (2012-2015)
Table 5-2: Analytik Jena Revenue (FY 2011-2014)
Table 5-3: Becton, Dickinson & Co. (BD) Revenue (FY 2012-2015)
Table 5-4: Biocartis NV Revenue (2012-2015)
Table 5-5: bioMérieux Revenue (2012-2015)
Table 5-6: Cepheid Revenue (2012-2015)
Table 5-7: DiaSorin Revenue (2012-2015)
Table 5-8: Eiken Chemical Revenue (FY 2012-2015)
Table 5-9: Epistem Revenue (FY 2012-2015)
Table 5-10: Great Basin Corporation Revenue (2012-2015)
Table 5-11: Meridian Bioscience Revenue (FY 2012-2015)
Table 5-12: Nanosphere Revenue (2012-2015)
Table 5-13: Orion Diagnostica Revenue (2012-2015)
Table 5-14: PositiveID Revenue (2012-2015)
Table 5-15: QIAGEN Revenue (2012-2015)
Table 5-16: Quidel Corporation Revenue (2012-2015)
Table 5-17: Roche Diagnostics Revenue (2012-2015)
Table 5-18: Seegene Revenue (2012-2015)
Table 5-19: T2 Biosystems Revenue (FY 2012-FY 2015)
THE WORLD MARKET FOR POINT OF CARE TESTS
EXECUTIVE SUMMARY
SCOPE AND METHODOLOGY
Size and Growth of the Market
Key Issues and Trends Affecting Market
Leading Competitors
INTRODUCTION
Point of Care Diagnostics Testing
Industry Regulations
POC Industry Drivers
Patent-Focused Drivers
Medical/Healthcare-Related Drivers
Technology Drivers
Economic Drivers
Other Drivers
POC Test Types
Blood
Urine
Saliva
Hair
Optical Technologies
Breath
CONDITIONS EVALUATED BY POC DIAGNOSTIC TESTING
Cancer
Colorectal Cancer
Prostate Cancer
Cardiovascular Disease
Diabetes
Drug Abuse
Club Drugs
GHB
Rohypnol
Ketamine
Narcotic Abuse
Heroin
Narcotic Analgesics
Opium
Central Nervous System Depressant Abuse
Sedative-Hypnotic/Antianxiety Abuse
Alcohol Abuse
Central Nervous System Stimulants
Amphetamine and Amphetamine-Like Agents
Ecstasy
Cocaine Abuse
Marijuana Abuse
Psychedelic Agents
Tobacco
Inhalant Abuse
Steroid Abuse
Miscellaneous Drugs of Abuse
Salvia
Bath Salts
Khat
DXM
Prevalence and Number of Illicit Drug Users
Infectious Disease
Herpes
HTLV
Respiratory Syncytial Virus
Hepatitis
Lyme Disease
Babesiosis
Gonorrhea, Syphilis and Chlamydia
Trichomonas Vaginalis
HIV/AIDS
Helicobacter Pylori
Influenza
Mononucleosis
Streptococcus
Osteoporosis
Pregnancy and Fertility
World Demographics
Global Aging Population
POC BLOOD GLUCOSE TESTS
Types of Blood Glucose Testing
Fasting Blood Sugar (FBS)
2-Hour Postprandial Blood Sugar (PPBS)
Random Blood Sugar
Glucose Tolerance Test
Glucose Urine Test
Glycated Hemoglobin (HbA1c)
Products
Blood Glucose Self-Testing
Continuous Self-Testing
Glycated Hemoglobin Tests
Professional
Market Size and Growth
POC Glucose Self-Testing
POC Glucose Professional Testing
Competitive Analysis
POC BLOOD AND ELECTROLYTES TESTING MARKET
Types of Blood and Electrolytes Tests
Hemoglobin/Hematocrit
WBC
Blood Gases
Electrolytes
Products
Market Size and Growth
POC Blood and Electrolyte Self-Testing
POC Blood and Electrolyte Professional Testing
Competitive Analysis
RAPID COAGULATION
Products
Platelet Testing
Market Size and Growth
POC Rapid Coagulation Self-Testing
POC Rapid Coagulation Professional Testing
Competitive Analysis
POC RAPID CARDIAC MARKERS
Products
Market Size and Growth
Competitive Analysis
POC SUBSTANCE ABUSE TESTING
Products
Urine
Oral
Blood
Hair
Market Size and Growth
POC Drugs of Abuse Self-Testing
POC Drugs of Abuse Professional Testing
Competitive Analysis
POC PREGNANCY AND FERTILITY TESTING
PRODUCTS
MARKET SIZE AND GROWTH
POC Pregnancy and Fertility Self-Testing
POC Pregnancy and Fertility Professional Testing
Competitive Analysis
POC COLON CANCER SCREENING/FECAL OCCULT BLOOD TESTING141
PRODUCTS
Market Size and Growth
POC Colon Cancer Screening/Fecal Occult Blood Self-Testing
POC Colon Cancer Screening/ Fecal Occult Blood Professional Testing
Competitive Analysis
POC INFECTIOUS DISEASE TESTING
PRODUCTS
MARKET SIZE AND GROWTH
POC Infectious Disease Self-Testing
POC Infectious Disease Professional Testing
Competitive Analysis
POC CHOLESTEROL TESTING
PRODUCTS
POC Cholesterol Self-Testing
POC Cholesterol Professional Testing
Competitive Analysis
POC CANCER TESTING
PRODUCTS
MARKET SIZE AND GROWTH
COMPETITIVE ANALYSIS
POC URINE STRIP TESTING
PRODUCTS
MARKET SIZE AND GROWTH
POC Urine Strip Self-Testing
POC Urine Test Strip Professional Testing
Competitive Analysis
MISCELLANEOUS POC TESTING
Microbiology
TSH
Allergy
Autoimmune
MARKET SIZE AND GROWTH
ISSUES AND TRENDS
Overview
Reimbursement Challenges
Competition
POC and Biosensors and Microfluidics
POC Connectivity
The Emergence of Non-Invasive Technologies
Saliva and Swab
Breath
Optical Techniques
TOTAL GLOBAL POC TESTING MARKET AND COMPETITOR ANALYSIS
Market Overview
Market Analysis by Product Categories
Market Analysis by Subcategory
POC Professional Testing
POC Self-Testing
Market Analysis by Country
United States
Europe
Germany
France
UK
Switzerland
Japan
Rest of World
China
India
Market Conclusions
Conclusion One
Conclusion Two
Conclusion Three
Conclusion Four
Competitive Analysis
SEVENTEEN: CORPORATE PROFILES
Overview
Abaxis, Inc
Company Overview
Product
Performance Review
Abbott Laboratories
Company Overview
Product
Performance Review
Accriva Diagnostics
Company Overview
Products
ACON Laboratories, Inc
Company Overview
Products
Alere Inc
Company Overview
Product
Performance Review
Arkray
Company Overview
Products
Beckman-Coulter, Inc.
Company Overview
Products
Performance Review
bioMerieux SA
Company Overview
Products
Performance Review
Church & Dwight Co., Inc
Company Overview
Products
Eiken Chemical Co Ltd.
Company Overview
Products
EKF Diagnostics GmbH
Company Overview
Products
Performance Review
Enterix, Inc
Company Overview
Products
Helena Laboratories
Company Overview
Products
Insight Pharmaceuticals LLC
Company Overview
Products
Instrumentation Laboratory
Company Overview
Products
LifeScan, Inc
Company Overview
Products
Performance Review
Macherey-Nagel GmbH & Co. KG
Company Overview
Products
Meridian BioScience, Inc
Company Overview
Products
Performance Review
Nova Biomedical, Corp.
Company Overview
Products
Opko Health, Inc
Company Overview
Products
Performance Review
OraSure Technologies, Inc
Company Overview
Products
Performance Review
ORTHO CLINICAL DIAGNOSTICS
Company Overview
Products
POLYMED THERAPEUTICS INC.
Polymedco, Inc
Company Overview
Products
POLYMER TECHNOLOGIES, INC (PTS DIAGNOSTICS)
Company Overview
Products
QUIDEL CORPORATION
Company Overview
Products
Performance Review
RADIOMETER MEDICAL APS
Company Overview
Products
RESPONSE BIOMEDICAL CORP
Company Overview
Products
Performance Review
ROCHE DIAGNOSTICS CORPORATION
Company Overview
Products
Performance Review
SIEMENS HEALTHCARE
Company Overview
Products
Performance Review
SYSMEX CORPORATION
Company Overview
Products
Performance Review
TRINITY BIOTECH PLC
Company Overview
Products
Performance Review
LIST OF COMPANIES
LIST OF TABLES AND FIGURES
ONE: EXECUTIVE SUMMARY
Table 1-1
Global POC Diagnostic Testing Market Analysis: 2012-2019
TWO: INTRODUCTION
Table 2-1
Traditional CLIA-Waived Tests
Table 2-2
Annual CLIA Test Waivers by Selected Analyte(s) (Drugs of Abuse and Therapeutic
Drugs, Urinalysis, Glucose Monitoring, General Chemistry, Infectious Diseases,
Other) (2010-2014)
Table 2-3
CLIA-Waived Tests and Analytes
Table 2-4
2014 CLIA Waivers (Manufacturer and Instrument / Assay)
Table 2-5
POC Tests – Ranked by Estimated Volume (2014)
Table 2-6
Types of Inhalants
Table 2-7
Annual Prevalence and Number of Illicit Drug Users Globally by Drug Type 2012
Table 2-8
Estimated Number and Prevalence of Drug Users by Region
Table 2-9
World Population by Selected Geographical Region, 2010 – 2050 (Africa, Asia,
Europe, Northern America, Oceania, Latin America and the Caribbean, World)
Figure 2-1
World Population by Selected Geographical Region, 2010–2050 (Africa, Asia, Europe,
Northern America, Oceania, Latin America and Caribbean)
Table 2-10
Estimated World Population by Age (0-14, 15-64, 65+, Men, Women, Total) and
Geographical Region (Africa, Asia, Europe, Northern America, Oceania, Latin
America and Caribbean, World), 2012
Figure 2-2
Estimated World Population by Age (0-14, 15-64, 65+) and Geographical Region(Africa, Asia, Europe, Northern America, Oceania, Latin America), 2012
Table 2-11
Percent Population Over 65 by Year and Region, 2010-2050 (Africa, Asia, Europe,
Northern America, Oceania, Latin America and the Caribbean, World)
Figure 2-3
Estimated World Population by Age, 2010 and 2050 (0-14, 15-64, 65+)
THREE: POC BLOOD GLUCOSE TESTS
Table 3-1
Selected Glucose Self-Test Meter Innovations
Table 3-2
Selected Apps and Glucose Management IT
Table 3-3
Selected Noninvasive Glucose Monitoring Devices
Table 3-4
Selected Continuous BGM Sales, 2014
Table 3-5
Selected Continuous Blood Glucose System Developments, 2014
Table 3-6
Selected POC HbA1c Devices
Table 3-7
Selected Innovations in POC Hospital-based Glucose Monitoring
Table 3-8
Global POC Glucose Testing Market Analysis: 2012-2019
Figure 3-1
Global POC Glucose Testing Market Analysis: 2012-2019
Table 3-9
Global POC Glucose Self-Testing Market Analysis, 2014 and 2019
Table 3-10
Global POC Glucose Professional Testing Market Analysis, 2014 and 2019
Table 3-11
Global POC Blood Glucose Testing Market Revenues and Market Share of Leading
Suppliers, 2014
Figure 3-2
Global POC Glucose Test Manufacturers by Percent, 2014
FOUR: POC BLOOD AND ELECTROLYTES TESTING MARKET
Table 4-1
Selected POC Hemoglobin and Hematocrit Systems, 2014
Table 4-2
Selected POC Hematology Analyzer Systems, 2014
Table 4-3
Global POC Blood and Electrolytes Testing Market Analysis: 2012-2019
Figure 4-1
Global POC Blood and Electrolytes Testing Market Analysis: 2012-2019
Table 4-4
Global POC Blood and Electrolyte Professional Testing Market Analysis, 2014 andm2019
Table 4-5
Global POC Blood and Electrolyte Testing Market Revenues and Market Share of Leading Suppliers, 2014
Figure 4-2
Global POC Blood and Electrolyte Testing Market Manufacturers by Percent, 2014
FIVE: RAPID COAGULATION
Table 5-1
Selected POC Coagulation Innovations
Table 5-2
Selected Platelet Activity Test Innovations
Table 5-3
Global Rapid Coagulation Testing Market Analysis: 2012-2019
Figure 5-1
Global Rapid Coagulation Testing Market Analysis: 2012-2019
Table 5-4
POC Rapid Coagulation Self-Testing Market Analysis, 2014 and 2019
Table 5-5
POC Rapid Coagulation Professional Testing Market Analysis, 2014 and 2019
Table 5-6
Global POC Rapid Coagulation Testing Market Revenues and Market Share of
Leading Suppliers, 2014
Figure 5-2
Global POC Rapid Coagulation Testing Manufacturers by Percent, 2014
SIX: POC RAPID CARDIAC MARKERS
Table 6-1
Total Rapid Cardiac Markers Tests Market Analysis, 2012-2019
Figure 6-1
Global POC Rapid Cardiac Markers Test Market Analysis, 2012-2019
Table 6-2
Global POC Cardiac Markers Test Market Revenues and Market Share of Leading Suppliers, 2014
Figure 6-2
Global POC Cardiac Test Manufacturers by Percent, 2014
SEVEN: POC SUBSTANCE ABUSE TESTING
Table 7-1
Global POC Drugs of Abuse Testing Market Analysis: 2012-2019
Figure 7-1
Global POC Drugs of Abuse Testing Market Analysis: 2012-2019
Table 7-2
Global POC Drugs of Abuse Self-Testing Market Analysis, 2014 and 2019
Table 7-3
Global POC Drugs of Abuse Professional Testing Market Analysis, 2014
and 2019
Table 7-4
Global POC Drugs of Abuse Testing Market Revenues and Market Share of Leading
Suppliers, 2014
Figure 7-2
Global POC Drug of Abuse Testing Manufacturers by Percent, 2014
EIGHT: POC PREGNANCY AND FERTILITY TESTING
Table 8-1
2014 Pregnancy and Fertility CLIA Waivers (Manufacturer and Instrument / Assay)
Table 8-2
Global POC Pregnancy and Fertility Testing Market Analysis: 2012-2019
Figure 8-1
Global POC Pregnancy and Fertility Testing Market Analysis: 2012-2019
Table 8-3
POC Pregnancy and Fertility Self-Testing Market Analysis, 2014 and 2019
Table 8-4
POC Pregnancy and Fertility Professional Testing Market Analysis, 2014 and 2019
Table 8-5
Global POC Pregnancy and Fertility Testing Market Revenues and Market Share of Leading Suppliers, 2014
Figure 8-2
Global POC Pregnancy and Fertility Testing Manufacturers by Percent, 2014
NINE: POC COLON CANCER SCREENING/FECAL OCCULT BLOOD TESTING
Table 9-1
Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market Analysis:
2012-2019
Figure 9-1
Global POC Colon Cancer Screening/ Fecal Occult Blood Testing Market Analysis:
2012-2019
Table 9-2
POC Colon Cancer Screening/Fecal Occult Blood Self-Testing Market Analysis,2014 and 2019
Table 9-3
POC Colon Cancer Screening/Fecal Occult Blood Professional Testing Market Analysis, 2014 and 2019
Table 9-4
Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market Revenues and Market Share of Leading Suppliers, 2014
Figure 9-2
Global POC Colon Cancer Screening/Fecal Occult Blood Testing Manufacturers by Percent, 2014
TEN: POC INFECTIOUS DISEASE TESTING
Table 10-1
Selected Professional-Use POC Tests for Infectious Diseases
Table 10-2
Global POC Infectious Disease Testing Market Analysis: 2012-2019
Table 10-3
POC Infectious Disease Self-Testing Market Analysis, 2014 and 2019
Table 10-4
POC Infectious Disease Professional Testing Market Analysis, 2014 and 2019
Table 10-5
Global POC Infectious Disease Testing Market Revenues and Market Share of
Leading Suppliers, 2014
Figure 10-2
Global POC Infectious Disease Test Manufacturers by Percent 2014
ELEVEN: POC CHOLESTEROL TESTING
Table 11-1
Global POC Cholesterol Testing Market Analysis: 2012-2019
Figure 11-1
Global POC Cholesterol Testing Market Analysis: 2012-2019
Table 11-2
POC Cholesterol Self-Testing Market Analysis, 2014 and 2019
Table 11-3
POC Cholesterol Professional Testing Market Analysis, 2014 and 2019
Table 11-4
Global POC Cholesterol Testing Market Revenues and Market Share of Leading
Suppliers, 2014
Figure 11-2
Global POC Cholesterol Testing Manufacturers by Percent, 2014
TWELVE: POC CANCER TESTING
Table 12-1
Selected Companies Developing and/or Marketing POC Tests for Hematology/Oncology Indications
Table 12-2
Global POC Cancer Testing Market Analysis: 2012-2019
Figure 12-1
Global POC Cancer Testing Market Analysis: 2012-2019
Table 12-3
Global POC Cancer Testing Market Revenues and Market Share of Leading
Suppliers, 2014
Figure 12-2
Global POC Cancer Testing Manufacturers by Percent, 2014
THIRTEEN: POC URINE STRIP TESTING
Table 13-1
Selected Dipstick Urinalysis Systems, 2014
Table 13-2
Global POC Urine Strip Testing Market Analysis: 2012-2019
Figure 13-1
Global POC Urine Strip Testing Market Analysis: 2012-2019
Table 13-3
POC Urine Strip Self-Testing Market Analysis, 2014 and 2019
Table 13-4
POC Urine Test Strip Professional Testing Market Analysis, 2014 and 2019
Table 13-5
Global POC Urine Strip Testing Market Revenues and Market Share of Leading
Suppliers, 2014
Figure 13-2
Global POC Urine Strip Testing Manufacturers by Percent, 2014
FOURTEEN: MISCELLANEOUS POC TESTING
Table 14-1
Global Miscellaneous POC Testing Market Analysis: 2012-2019
Figure 14-1
Global Miscellaneous POC Testing Market Analysis: 2012-2019
FIFTEEN: ISSUES AND TRENDS
Table 15-1
Selected Biochip and Biosensor Players, 2014
Table 15-2
Selected Disease Markers in Exhaled Breath (Asthma, Breast cancer, Diabetes, Liver function, Lung cancer, Organ rejection, Renal function, Schizophrenia, Gastrointestinal malabsorption / Irritable Bowel Syndrome (IBS) / Celiac disease and food
intolerances / Bacterial overgrowth, Bacterial infection)
SIXTEEN: TOTAL GLOBAL POC TESTING MARKET AND
COMPETITOR ANALYSIS
Table 16-1
Global POC Testing Market Analysis: 2012-2019
Figure 16-1
Global POC Testing Market Analysis: 2012-2019
Table 16-2
Global POC Testing Market Analysis by Product Category, 2014 (Professional,
Self-Testing, Total)
Figure 16-2
Global POC Testing Market Analysis by Product Category, 2014 (Self-Test,
Professional)
Table 16-3
Global POC Professional Testing Market Analysis by Product Subcategory, 2014(Drugs of Abuse, Blood & Electrolytes, Glucose, Infectious Disease, Rapid Coagulation, Cardiac Markers, Fecal Occult Blood, Cholesterol, Pregnancy & Fertility, Miscellaneous, Urine Strip, Cancer, Total)
Figure 16-3
Global POC Professional Market Analysis by Product Subcategory, 2014 (Blood, DOA)
Table 16-4
Global POC Self-Testing Market Analysis by Product Category, 2014 (Glucose,
Pregnancy & Fertility, Fecal Occult Blood, Raid Coagulation, Drugs of Abuse, Urine Strip, Infectious Disease, Cholesterol, Total)
Figure 16-4
Global POC Self-Testing Market Analysis by Product Category, 2014 (PG, Glucose)
Table 16-5
Number of POCs in the United States (Compliance [Moderate and High Complexity], Waiver, Provider-Perfomed Microscopy [PPM], Accreditation [Moderate and High Complexity]) (2005-2013)
Table 16-6
Global POC Testing Market Analysis by Region/Country, 2014 (United States, Europe, Japan, ROW, Total)
Figure 16-5
Global POC Testing Market Analysis by Region/Country, 2014 (US, Europe, Japan, ROW)
Figure 16-6
Global POC Testing Market Analysis by Region/Country, 2019 (US, Europe, Japan, ROW)
Table 16-7
Global EU POC Testing Market Analysis by European Region, 2014(EU W. Europe, EU E. Europe)
Figure 16-7
Global EU POC Testing Market Analysis by European Region, 2014(W. Europe, E. Europe)
Table 16-8
Global POC Testing Market Analysis by Rest of World Region/Country, 2014(China, India, Brazil, Others, Total)
Figure 16-8
Global POC Testing Market Analysis by Rest of World Region/Country, 2014(China, India, Brazil, Others)
Table 16-9
Global POC Testing Market Revenues and Market Share of Leading Suppliers, 2014
Figure 16-9
Global POC Testing Market Share by Leading Suppliers, 2014
SEVENTEEN: CORPORATE PROFILES
Figure 17-1
Abaxis Medical Revenues 2012-2014
Figure 17-2
Abbott Laboratories Revenues 2012-2014
Figure 17-3
Alere Laboratories Revenues 2012-2014
Figure 17-4
Danaher Life Sciences and Diagnostic Businesses Revenues 2012-2014
Figure 17-5
bioMerieux Revenues 2012-2014
Figure 17-6
Church & Dwight Revenues 2012-2014
Figure 17-7
Eiken Chemical Revenues 2012-2014
Figure 17-8
EKF Diagnostics Revenues 2012-2014
Figure 17-9
LifeScan Revenues 2012-2014
Figure 17-10
Meridian BioScience Revenues 2012-2014
Figure 17-11
OPKO Health Revenues 2012-2014
Figure 17-12
OraSure Revenues 2012-2014
Figure 17-13
Quidel Revenues 2012-2014
Figure 17-14
Response Biomedical Revenues 2012-2014
Figure 17-15
Roche Diagnostics Revenues 2012-2014
Figure 17-16
Siemens Revenues 2012-2014
Figure 17-17
Sysmex Revenues 2012-2014
Figure 17-18
Trinity Biotech Revenues 2012-2014
